Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winder

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Gastroenterology|April 28, 2010
Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancerThomas Winder, Heinz-Josef Lenz
Cancer Treatment Reviews|April 6, 2010
Molecular predictive and prognostic markers in colon cancerThomas Winder, Heinz-Josef Lenz
The Oncologist|July 27, 2010
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapyThomas Winder, Heinz-Josef Lenz
The Lancet. Oncology|July 13, 2010
Beyond KRAS: a new approach in metastatic colorectal cancerThomas Winder, Heinz-Josef Lenz
Case Reports in Oncology|May 12, 2021
Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported OutcomeMagdalena Pircher, Thomas Winder, Andreas Trojan
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerThomas Winder, Werner Scheithauer, Alois Lang
Muscle & Nerve|October 31, 2013
DNAJB6 myopathy: a vacuolar myopathy with childhood onsetGerson Suarez-Cedeno, Thomas Winder, Margherita Milone
BMC Cancer|February 14, 2023
What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?Rahel Stiefel, Kuno Lehmann, Thomas Winder, et al.
The Laryngoscope|September 13, 2014
Aggressive primary olfactory neuroblastoma of the sphenoclival region: a case report and literature reviewBela Purohit, Thomas Winder, Ewerton M Maggio, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2019
Metastatic Mixed Adenoneuroendocrine Carcinoma of the Colon with Response to Immunotherapy with Pembrolizumab: A Case ReportAmelie Stueger, Thomas Winder, Marianne Tinguely, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Gastroenterology|April 28, 2010
Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancerThomas Winder, Heinz-Josef Lenz
Cancer Treatment Reviews|April 6, 2010
Molecular predictive and prognostic markers in colon cancerThomas Winder, Heinz-Josef Lenz
The Oncologist|July 27, 2010
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapyThomas Winder, Heinz-Josef Lenz
The Lancet. Oncology|July 13, 2010
Beyond KRAS: a new approach in metastatic colorectal cancerThomas Winder, Heinz-Josef Lenz
Case Reports in Oncology|May 12, 2021
Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported OutcomeMagdalena Pircher, Thomas Winder, Andreas Trojan
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerThomas Winder, Werner Scheithauer, Alois Lang
Muscle & Nerve|October 31, 2013
DNAJB6 myopathy: a vacuolar myopathy with childhood onsetGerson Suarez-Cedeno, Thomas Winder, Margherita Milone
BMC Cancer|February 14, 2023
What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?Rahel Stiefel, Kuno Lehmann, Thomas Winder, et al.
The Laryngoscope|September 13, 2014
Aggressive primary olfactory neuroblastoma of the sphenoclival region: a case report and literature reviewBela Purohit, Thomas Winder, Ewerton M Maggio, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2019
Metastatic Mixed Adenoneuroendocrine Carcinoma of the Colon with Response to Immunotherapy with Pembrolizumab: A Case ReportAmelie Stueger, Thomas Winder, Marianne Tinguely, et al.
Pageof 10